Stay updated on CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Sign up to get notified when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.

Latest updates to the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page
- Check3 days agoChange DetectedUI tweaks and updated timestamps observed; core study details remain unchanged.SummaryDifference0.1%

- Check10 days agoChange DetectedAdded 'Atypical teratoid rhabdoid tumor' to the study's keywords/MeSH terms.SummaryDifference0.0%

- Check17 days agoChange DetectedNo significant changes detected between the two screenshots; core study information and page structure appear unchanged.SummaryDifference0.1%

- Check24 days agoChange DetectedAdded revision note v3.4.2 and removed an earlier downtime notice about government funding; this is a minor maintenance update (To avoid being alerted by small changes, set an alert condition by clicking below).SummaryDifference0.4%

- Check31 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH operations was added, and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check38 days agoChange DetectedGlossary display option added; QC-related labels and site metadata updated (including Revision: v3.4.0 and capitalization tweaks for Last Update Submitted that Met QC Criteria and No FEAR Act data).SummaryDifference0.2%

Stay in the know with updates to CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLR 131 Dose Escalation in Pediatric Malignancy Clinical Trial page.